Affluent Medical Announces the Launch of the MINERVA First-In-Human Clinical Study of EPYGON EPYGON is the first native-like transcatheter mitral valve replacement technology aiming at achieving better clinical outcomes The Austrian Competent Authority has granted authorization to start patient enrollment at Vienna General Hospital (AKH) The EPYGON valve has the potential to become a new paradigm in the treatment of functional
June 24, 2020
· 5 min read
